Ryan Nicholson - 13 Feb 2026 Form 4 Insider Report for Dolby Laboratories, Inc. (DLB)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
17 Feb 2026, 17:57:48 UTC
Prior SEC filing
17 Dec 2025
Next SEC filing
06 Aug 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Daniel Rodriguez as Attorney-in-Fact for Ryan Nicholson

Key filing fact

Ryan Nicholson filed Form 4 for Dolby Laboratories, Inc. (DLB) on 17 Feb 2026.

Key facts

  • This page summarizes Ryan Nicholson's Form 4 filing for Dolby Laboratories, Inc. (DLB).
  • 3 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 17 Feb 2026, 17:57.

Change

  • Previous filing in this sequence was filed on 17 Dec 2025.
  • Current net transaction value: -$55,674.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001767009 Primary reporting owner

Nicholson Ryan

Relationship
VP, CAO and Corp. Controller
Address
C/O DOLBY LABORATORIES, INC., 1275 MARKET STREET, SAN FRANCISCO
Signature
/s/ Daniel Rodriguez as Attorney-in-Fact for Ryan Nicholson
Signature date
17 Feb 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

DLB transaction

Class A Common Stock

Options Exercise

Transaction value
$121,348
Shares
+2,667
Change %
+7.2%
Price
$45.50
Shares after
39,623
Date
13 Feb 2026
Ownership
Direct
Footnotes
F1
DLB transaction

Class A Common Stock

Sale

Transaction value
$177,023
Shares
-2,667
Change %
-6.7%
Price
$66.38
Shares after
36,956
Date
13 Feb 2026
Ownership
Direct
Footnotes
F1, F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

DLB transaction Derivative

Employee Stock Option (Right to Buy)

Options Exercise

Transaction value
$0
Shares
-2,667
Change %
-100%
Price
$0.000000
Shares after
0
Date
13 Feb 2026
Ownership
Direct
Underlying class
Class A Common Stock
Underlying amount
2,667
Exercise price
$45.50
Footnotes
F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Shares held following the reported transactions include 19,303 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest.

Footnote F2

The shares were sold in multiple transactions at prices ranging from $66.37 to $66.39, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.

Footnote F3

This option was granted for a total of 2,667 shares of Class A Common Stock. The option exercised in this transation was fully vested and exercisable as of the transaction date.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .